Browse by Academic Unit (A-Z)

A

Adusumilli, P. orcid.org/0000-0002-1567-9795, Ravikumar, N. orcid.org/0000-0003-0134-107X, Hall, G. orcid.org/0000-0002-8864-5932 et al. (3 more authors) (2023) Radiomics in the evaluation of ovarian masses — a systematic review. Insights into Imaging, 14 (1). 165.

Alzahrani, N.M., Henry, A. orcid.org/0000-0002-5379-6618, Clark, A.K. orcid.org/0000-0003-4359-3697 et al. (3 more authors) (2023) Geometric evaluations of CT and MRI based deep learning segmentation for brain OARs in radiotherapy. Physics in Medicine & Biology, 68 (17). 175035. ISSN 0031-9155

Andratschke, N., Willmann, J., Appelt, A.L. orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2022) European Society for Radio-therapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology, 23 (10). e469-e478. ISSN 1470-2045

Andrews, L.J. orcid.org/0000-0001-5595-1987, Thornton, Z.A. orcid.org/0000-0001-9275-7198, Saleh, R. et al. (6 more authors) (2023) Genomic landscape and actionable mutations of brain metastases derived from non–small cell lung cancer: A systematic review. Neuro-Oncology Advances, 5 (1). vdad145. ISSN 2632-2498

Arp, D.T. orcid.org/0009-0007-7980-5539, Appelt, A.L. orcid.org/0000-0003-2792-9218, Jensen, L.H. et al. (6 more authors) (2024) Treatment planning for patients with low rectal cancer in a multicenter prospective organ preservation study. Physica Medica, 118. 103206. ISSN 1120-1797

B

Baxter, M.A. orcid.org/0000-0002-5773-8650, Spender, L.C., Walsh, S. et al. (6 more authors) (2023) Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma—A Post-hoc Analysis of the GO2 Trial. Cancers, 15 (9). 2591. ISSN 2072-6694

Bhaskaran, D., Savage, J., Patel, A. et al. (9 more authors) (2024) A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial. BMC Cancer, 24 (1). 83. ISSN 1471-2407

Boele, F. orcid.org/0000-0003-0409-7949, Kawalek, J., Nicklin, E. et al. (2 more authors) (2023) Living with an artificial eye: qualitative insights into patient and family member experiences. International Ophthalmology. ISSN 0165-5701 (In Press)

Boele, F.W. orcid.org/0000-0003-0409-7949, Butler, S., Nicklin, E. et al. (3 more authors) (2022) P08.05.B Communication in the context of glioblastoma treatment: what matters most to patients and caregivers. In: Neuro-Oncology. Abstracts from the 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii43-ii44.

Boele, F.W. orcid.org/0000-0003-0409-7949, Rudkin, S.E., Absolom, K. orcid.org/0000-0002-5477-6643 et al. (3 more authors) (2023) The experience of interval scans for adults living with primary malignant brain tumors. Supportive Care in Cancer, 31 (6). 356. ISSN 0941-4355

Bozovic Spasojevic, I. orcid.org/0000-0003-0678-9850, Ferrari, A. orcid.org/0000-0002-4724-0517, De Munter, J. et al. (12 more authors) (2023) Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey. Tumori Journal. ISSN 0300-8916

Breen, J. orcid.org/0000-0002-9020-3383, Allen, K., Zucker, K. orcid.org/0000-0003-4385-3153 et al. (5 more authors) (2023) Artificial intelligence in ovarian cancer histopathology: a systematic review. npj Precision Oncology, 7. 83. ISSN 2397-768X

Brüning-Richardson, A. orcid.org/0000-0002-9862-9805, Shaw, G. C. orcid.org/0000-0001-9344-4433, Tams, D. et al. (17 more authors) (2021) GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers, 13 (23). 5939. ISSN 2072-6694

Brüning-Richardson, A. orcid.org/0000-0002-9862-9805, Shaw, G.C. orcid.org/0000-0001-9344-4433, Tams, D. et al. (17 more authors) (2022) Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. Cancers, 14 (15). 3789. ISSN 2072-6694

Brüning-Richardson, A. orcid.org/0000-0002-9862-9805, Shaw, G.C. orcid.org/0000-0001-9344-4433, Tams, D. et al. (17 more authors) (2022) Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. Cancers, 14 (15). 3789. ISSN 2072-6694

C

Calvert, M.J., Cruz, S., Retzer, A. et al. (19 more authors) (2023) Patient reported outcome assessment must be inclusive and equitable. In: 6th National Patient Reported Outcome Measures (PROMs) Annual UK Research Virtual Conference, 14-15 Jun 2022, Bridgend + Virtual.

Cornford, P., van den Bergh, R.C.N., Briers, E. et al. (28 more authors) (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology. ISSN 0302-2838

Crossnohere, N.L. orcid.org/0000-0002-2811-1330, Anderson, N., Baumhauer, J. orcid.org/0000-0003-2142-7778 et al. (15 more authors) (2024) A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide. Nature Medicine. ISSN 1078-8956

Currie, S. orcid.org/0000-0002-0154-6588, Fatania, K. orcid.org/0000-0003-2421-1083, Frood, R. orcid.org/0000-0003-2681-9922 et al. (11 more authors) (2023) Imaging Spectrum of the Developing Glioblastoma: A Cross-Sectional Observation Study. Current Oncology, 30 (7). pp. 6682-6698. ISSN 1198-0052

D

Dawkins, B. orcid.org/0000-0002-7038-1975, Absolom, K. orcid.org/0000-0002-5477-6643, Hewison, J. orcid.org/0000-0003-3026-3250 et al. (13 more authors) (2024) Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy. JCO Oncology Practice. ISSN 2688-1527

de Ligt, K.M., Koppert, L.B., de Rooij, B.H. et al. (3 more authors) (2024) Seizing the moment: The time for harnessing electronic patient-reported outcome measures for enhanced and sustainable metastatic breast cancer care is now. The Breast, 74. 103676. ISSN 0960-9776

de Ligt, K.M., de Rooij, B.H., Koppert, L.B. et al. (3 more authors) (2023) Patient-reported outcome measures to improve the care continuum for patients with metastatic breast cancer: opportunities and implications for nursing practice. Seminars in Oncology Nursing, 39 (6). 151510. ISSN 0749-2081

E

Elhaminia, B., Gilbert, A. orcid.org/0000-0002-9142-1227, Frangi, A.F. orcid.org/0000-0002-2675-528X et al. (5 more authors) (2023) Deep learning with visual explanation for radiotherapy-induced toxicity prediction. In: Iftekharuddin, K.M. and Chen, W., (eds.) Medical Imaging 2023: Computer-Aided Diagnosis. SPIE Medical Imaging, 19-24 Feb 2023, San Diego, CA, USA. SPIE . ISBN 9781510660359

F

Fatania, K. orcid.org/0000-0003-2421-1083, Frood, R. orcid.org/0000-0003-2681-9922, Tyyger, M. et al. (16 more authors) (2022) Exploratory Analysis of Serial 18F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for Glioblastoma. Cancers, 14 (14). 3485. ISSN 2072-6694

Frances, S.M., Murray, L., Nicklin, E. et al. (2 more authors) (2024) Long-term health-related quality of life in meningioma survivors: a mixed-methods systematic review. Neuro-Oncology Advances. ISSN 2632-2498

G

Goldberg, I., Sherwood, P., Sereika, S. et al. (6 more authors) (2023) Predictors of Healthcare Utilization in Family Caregivers of Persons With a Primary Malignant Brain Tumor. Journal of Neuroscience Nursing. ISSN 0888-0395

Gout, T., Zoltie, T., Woodward, A. orcid.org/0000-0002-9579-4012 et al. (10 more authors) (2023) A cross-over, randomised feasibility study of digitally printed versus hand-painted artificial eyes in adults: PERSONAL-EYE-S - a study protocol [version 2; peer review: 2 approved]. NIHR Open Research. ISSN 2633-4402

Green, S.M.C. orcid.org/0000-0002-2622-5377, Hall, L.H., Rousseau, N. et al. (17 more authors) (2023) Acceptability, fidelity and trial experience of four intervention components to support medication adherence in women with breast cancer: A process evaluation protocol for a pilot fractional factorial trial. NIHR Open Research, 3 (3). ISSN 2633-4402

H

Harkness, R., Frangi, A.F. orcid.org/0000-0002-2675-528X, Zucker, K. orcid.org/0000-0003-4385-3153 et al. (1 more author) (2023) Learning disentangled representations for explainable chest x-ray classification using Dirichlet VAEs. In: Išgum, I. and Colliot, O., (eds.) Medical Imaging 2023: Image Processing. SPIE Medical Imaging, 19-24 Feb 2023, San Diego, CA, USA. SPIE . ISBN 978-1-5106-6033-5

Harper-Wynne, C., Owen, J., Velikova, G. orcid.org/0000-0003-1899-5942 et al. (3 more authors) (2023) A disease registry study to prospectively observe treatment patterns and outcomes in patients with HER2+unresectable locally advanced or metastatic breast cancer (aBC): Interim results of the ESTHER study (NCT02393924). In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, IL. American Society of Clinical Oncology , Alexandria, Virginia, USA .

Hartup, S.M., Ashley, L., Briggs, M. et al. (2 more authors) (2023) Developing and feasibility testing a web-based intervention (ePainQ) to support post-operative pain and symptom self-management following surgery for breast cancer. In: Cancer Research. 2022 San Antonio Breast Cancer Symposium, 06-10 Dec 2022, San Antonio, Texas. Poster Session Abstracts, 83 (5). American Association for Cancer Research , Philadelphia, Pennsylvania .

Hassanieh, S., Domingo, E., Blake, A. et al. (16 more authors) (2022) 337P Prediction of poor response to oxaliplatin by an RNA signature derived and validated in colorectal cancer clinical trials. In: Annals of Oncology. ESMO Congress 2022, 09-13 Sep 2022, Paris, France. Elsevier , S691.

Henry, A. orcid.org/0000-0002-5379-6618, Holch, P., Routledge, J. et al. (6 more authors) (2021) Pilot randomised trial of online self-monitoring of symptoms during pelvic radiotherapy. In: International Journal of Radiation Oncology, Biology, Physics. ESTRO 2020, 2020-11-28 - 2020-12-1, Vienna, Austria. Proffered Papers: Proffered papers 14: QoL and PROMs, 152 (Supplement 1). Elsevier , S164-S165.

Holch, P. orcid.org/0000-0002-4255-8315, Turner, G., Keetharuth, A.D. et al. (3 more authors) (2023) The impact of COVID-19 on PRO development, collection and implementation: views of UK and Ireland professionals. Journal of Patient-Reported Outcomes, 7. 121. ISSN 2509-8020

Huddart, R., Birtle, A., Cheung, K.C. et al. (19 more authors) (2023) Randomised phase II trial of adaptive image guided bladder radiotherapy: Disease control data. In: Radiotherapy & Oncology. ESTRO 2023, 13-16 May 2023, Vienna, Austria. Elsevier , S704-S705.

Huddart, R., Birtle, A., Cheung, K.C. et al. (19 more authors) (2023) Randomised phase II trial of adaptive image guided bladder radiotherapy: patient reported outcomes. In: Radiotherapy & Oncology. ESTRO 2023, 13-16 May 2023, Vienna, Austria. Elsevier , S331-S332.

Huddart, R., Hafeez, S., Omar, A. et al. (25 more authors) (2023) Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial. Clinical Oncology, 35 (9). pp. 586-597. ISSN 0936-6555

Huddart, R.A., Hafeez, S., Omar, A. et al. (17 more authors) (2023) Randomised phase II trial of adaptive image guided radiotherapy in muscle invasive bladder cancer: Late toxicity and cancer outcomes. In: Journal of Clinical Oncology. 2023 ASCO Genitourinary Cancers Symposium, 16-18 Feb 2023. American Society of Clinical Oncology .

Hughes, L., Taylor, R.M. orcid.org/0000-0002-0853-0925, Beckett, A.E. orcid.org/0000-0001-5233-3390 et al. (7 more authors) (2024) The Emotional Impact of a Cancer Diagnosis: A Qualitative Study of Adolescent and Young Adult Experience. Cancers, 16 (7). 1332. ISSN 2072-6694

Hughes, N.F. orcid.org/0000-0003-2956-1760, Cromie, K.J. orcid.org/0000-0002-2859-5291, Feltbower, R.G. orcid.org/0000-0002-1728-9408 et al. (2 more authors) (2024) Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration data. International Journal of Cancer, 154 (5). pp. 816-829. ISSN 0020-7136

Hughes, N.F., Fern, L.A., Polanco, A. et al. (7 more authors) (2023) Patient and public involvement to inform priorities and practice for research using existing healthcare data for children’s and young people’s cancers. Research Involvement and Engagement, 9 (1). 71. ISSN 2056-7529

Huynh, K.A. orcid.org/0000-0002-7137-1074, Coopmans, E.C. orcid.org/0000-0003-4780-2468, Zamanipoor Najafabadi, A.H. orcid.org/0000-0003-2400-2070 et al. (13 more authors) (2023) Correction to: Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of Neuro-Oncology, 161 (2). p. 371. ISSN 0167-594X

Huynh, K.A. orcid.org/0000-0002-7137-1074, Coopmans, E.C. orcid.org/0000-0003-4780-2468, Zamanipoor Najafabadi, A.H. orcid.org/0000-0003-2400-2070 et al. (13 more authors) (2023) Healthcare utilization and costs among intracranial meningioma patients during long-term follow-up. Journal of Neuro-Oncology, 161 (2). pp. 357-370. ISSN 0167-594X

K

Khoury, E.G. orcid.org/0000-0003-2559-2762, Nuamek, T., Heritage, S. et al. (11 more authors) (2023) Geriatric Oncology as an Unmet Workforce Training Need in the United Kingdom—A Narrative Review by the British Oncology Network for Undergraduate Societies (BONUS) and the International Society of Geriatric Oncology (SIOG) UK Country Group. Cancers, 15 (19). 4782. ISSN 2072-6694

King, M.T. orcid.org/0000-0001-7192-2887, Revicki, D.A. orcid.org/0000-0001-6780-0019, Norman, R. orcid.org/0000-0002-3112-3893 et al. (27 more authors) (2024) United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument. PharmacoEconomics - Open, 8 (1). pp. 49-63. ISSN 2509-4262

L

Lee, M., Baird, A.-M., Brown, S. et al. (17 more authors) (2023) The evolving value assessment of cancer therapies: Principles from the cancer community. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, IL. American Society of Clinical Oncology , Alexandria, Virginia, USA .

Lee, M., Larose, H. orcid.org/0000-0003-4678-6048, Gräbeldinger, M. et al. (20 more authors) (2024) The evolving value assessment of cancer therapies: Results from a modified Delphi study. Health Policy OPEN, 6. 100116. ISSN 2590-2296

M

Marra, G., van Leenders, G.J.L.H., Zattoni, F. et al. (31 more authors) (2023) Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review. European Urology, 84 (1). pp. 65-85. ISSN 0302-2838

N

Nicklin, E., Jopson, J. and Boele, F. orcid.org/0000-0003-0409-7949 (2022) P08.09.A Improving support for family carers: Creating a cross-sector collaborative working group. In: Neuro-Oncology. 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii44-ii45.

Nicklin, E., Phang, I., Short, S. orcid.org/0000-0003-4423-7256 et al. (2 more authors) (2022) QOL-19. RETURNING TO WORK AFTER A BRAIN TUMOUR – “I THOUGHT I WOULD BE BACK AT WORK THE NEXT WEEK, HOW WRONG I WAS!”. In: Neuro-Oncology. 27th Annual Meeting and Education Day of the Society for Neuro-Oncology, 16-20 Nov 2022, Florida, USA. Oxford University Press , vii245-vii245.

Nicklin, E. orcid.org/0000-0002-6683-8098, Phang, I. orcid.org/0000-0002-1516-3043, Short, S.C. orcid.org/0000-0003-4423-7256 et al. (2 more authors) (2023) Patient and caregiver return to work after a primary brain tumour. Neuro-Oncology Practice. npad039. ISSN 2054-2577

O

Oort, Q., Koekkoek, J., Aaronson, N.K. et al. (21 more authors) (2022) PL02.4.A International validation study of an EORTC instrument measuring instrumental activities of daily living (IADL) in patients with brain tumours: EORTC IADL-BN32. In: Neuro-Oncology. 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii3-ii3.

P

Perry, M.B. orcid.org/0009-0002-2978-2272, Taylor, S., Khatoon, B. et al. (6 more authors) (2023) Effectiveness of electronic patient-reported outcomes in people with cancer: a systematic review and meta-analysis. [Preprint]

Piil, K. and Boele, F. orcid.org/0000-0003-0409-7949 (2023) Paving the Way to Evidence-Based Clinical Practice: Establishing Effective Caregiver and Family Support Interventions. Neuro-Oncology Practice. npad041. ISSN 2054-2577

Platt, J.R., Williams, C. orcid.org/0000-0002-1574-653X, West, N. orcid.org/0000-0002-0346-6709 et al. (2 more authors) (2023) Exploring the radiological differences of lymph nodes between mismatch repair deficient and mismatch repair proficient colon cancer. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, USA. American Society of Clinical Oncology .

R

Riviere-Cazaux, C. orcid.org/0000-0002-8857-4345, Carlstrom, L.P., Neth, B.J. et al. (17 more authors) (2023) An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence. npj Precision Oncology, 7 (1). 126. ISSN 2397-768X

Rogers, Z., Glaser, A., Catto, J.W.F. et al. (17 more authors) (2023) Quality of life after a diagnosis of Bladder Cancer: Longitudinal survey over the first year. BJU International. ISSN 1464-4096

Rudkin, S., Booth, T.C., Absolom, K. orcid.org/0000-0002-5477-6643 et al. (3 more authors) (2022) OS09.5.A The experience of interval scans for adults living with primary malignant brain tumours. In: Neuro-Oncology. 17th Meeting of the European Association of Neuro-Oncology, 15-18 Sep 2022, Vienna, Austria. Oxford University Press , ii20-ii20.

S

Seligmann, J., Morton, D., Seymour, M. et al. (11 more authors) (2023) 552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel. In: Annals of Oncology. ESMO Congress 2023, 2023-10-20 2023-10-24, Madrid, Spain. Elsevier , S412-S412.

Slevin, F. orcid.org/0000-0002-7176-904X, Zattoni, F., Checcucci, E. et al. (27 more authors) (2023) A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer. European Urology Oncology. ISSN 2588-9311

Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) Measuring What Matters To Adolescents And Young Adults With Cancer: The Importance Of Capturing Positive Experiences. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S15-S16.

Sodergren, S., Husson, O., Rohde, G. et al. (17 more authors) (2023) "Sometimes We Think About It But Don't Talk About It" Asking Adolescents And Young Adults With Cancer To Evaluate Sensitive Areas Of Life. In: Pediatric Blood & Cancer. 55th Congress of the International Society of Paediatric Oncology (SIOP), 11-14 Oct 2023, Ottawa, Canada. Wiley , S17-S17.

T

Tanner, G., Finetti, M.A., Pollock, S. et al. (13 more authors) (2022) IDHwt Glioblastomas Show Opposing Resistance Mechanisms Across Patients in Response to Standard Treatment. In: BNOS 2022, 22-24 Jun 2022, Liverpool.

Taylor, R.M. orcid.org/0000-0002-0853-0925, Whelan, J.S. orcid.org/0000-0001-6793-5722, Barber, J.A. orcid.org/0000-0001-5762-762X et al. (5 more authors) (2024) The Impact of Specialist Care on Teenage and Young Adult Patient-Reported Outcomes in England: A BRIGHTLIGHT Study. Journal of Adolescent and Young Adult Oncology. ISSN 2156-5333

Tvilum, M. orcid.org/0000-0001-9250-1678, Knap, M.M., Hoffmann, L. orcid.org/0000-0002-3575-0421 et al. (10 more authors) (2024) Early radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC. Clinical and Translational Radiation Oncology, 45. 100737. ISSN 2405-6308

Tvilum, M., Lutz, C.M., Knap, M.M. et al. (8 more authors) (2023) Different benefits of adaptive radiotherapy for different histologies of NSCLC. Acta Oncologica, 62 (11). pp. 1426-1432. ISSN 0284-186X

U

Unni, E., Coles, T., Lavallee, D.C. et al. (3 more authors) (2023) Patient adherence to patient-reported outcome measure (PROM) completion in clinical care: current understanding and future recommendations. Quality of Life Research, 33. pp. 281-290. ISSN 0962-9343

Unni, E., Coles, T., Lavallee, D.C. et al. (3 more authors) (2023) Patient adherence to patient-reported outcome measure (PROM) completion in clinical care: current understanding and future recommendations. Quality of Life Research. ISSN 0962-9343

V

Vasudev, N.S. orcid.org/0000-0001-8470-7481, Ainsworth, G., Brown, S. et al. (24 more authors) (2023) Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM). Journal of Clinical Oncology. ISSN 0732-183X

Velikova, G. orcid.org/0000-0003-1899-5942, Morden, J.P., Haviland, J.S. et al. (14 more authors) (2023) Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial. The Lancet Oncology. ISSN 1470-2045

W

Wagner, S.J., Reisenbüchler, D., West, N.P. et al. (46 more authors) (2023) Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study. Cancer Cell, 41. ISSN 1535-6108

Walker, K. orcid.org/0000-0001-6922-9100, Hinsley, S., Phillip, R. orcid.org/0000-0002-9604-9276 et al. (6 more authors) (2022) Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations—CONCORDE. JCO Precision Oncology, 6 (6). e2200133. ISSN 2473-4284

Williams, C. orcid.org/0000-0002-1574-653X, Elliott, F., Shires, M. et al. (17 more authors) (2023) Association between artificial intelligence (AI) -assisted tumor AREG and EREG immunohistochemistry (IHC) and outcomes from anti-EGFR therapy during the routine management of metastatic colorectal cancer (mCRC): An observational cohort study. In: Journal of Clinical Oncology. 2023 ASCO Gastrointestinal Cancers Symposium, 19-21 Jan 2023, San Francisco, USA. American Society of Clinical Oncology , p. 203.

Williams, C. orcid.org/0000-0002-1574-653X, Gray, R.G., Shires, M. et al. (17 more authors) (2023) Artificial intelligence-assisted evaluation of tumor infiltrating CD3+ and CD8+ T cells for prognostication and prediction of benefit from adjuvant chemotherapy in early stage colorectal cancer (CRC): A retrospective analysis of the QUASAR trial. In: Journal of Clinical Oncology. 2023 ASCO Gastrointestinal Cancers Symposium, 19-21 Jan 2023, San Francisco, USA. American Society of Clinical Oncology , p. 204.

Williams, C. orcid.org/0000-0002-1574-653X, Saunderson, C., Liu, J. et al. (4 more authors) (2022) Cardiac toxicities of fluoropyrimidine chemotherapy: A literature review and evaluation of current practice at a large U.K. cancer center. In: Journal of Clinical Oncology. 2022 ASCO Gastrointestinal Cancers Symposium, 20-22 Jan 2022, San Francisco, USA. American Society of Clinical Oncology , p. 72.

Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.

Williams, C. orcid.org/0000-0002-1574-653X, White, M., Platt, J.R. et al. (14 more authors) (2023) The FOxTROT platform: Clinical trials and exploratory research for personalization of neoadjuvant (NA) therapy in locally advanced colon cancer (LACC)—ISRCTN83842641. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, USA. American Society of Clinical Oncology .

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Elliott, F. orcid.org/0000-0002-3239-6914, Sapanara, N. orcid.org/0009-0005-0994-837X et al. (51 more authors) (2023) Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer. Clinical Cancer Research, 29 (20). pp. 4153-4165. ISSN 1078-0432

Williams, C.J.M. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Elliott, F. et al. (24 more authors) (2021) Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer. Clinical Cancer Research, 27 (12). pp. 3422-3431. ISSN 1078-0432

Wojcik, Z. orcid.org/0009-0007-6214-7736, Dimitrova, V. orcid.org/0000-0002-7001-0891, Warrington, L. orcid.org/0000-0002-8389-6134 et al. (2 more authors) (2024) Using Machine Learning to Predict Unplanned Hospital Utilisation and Chemotherapy Management from Patient-Reported Outcome Measures. JCO Clinical Cancer Informatics, 8. e2300264. ISSN 2473-4276

Y

Young, T., Velikova, G. orcid.org/0000-0003-1899-5942, Liegl, G. et al. (2 more authors) (2024) EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population. European Journal of Cancer. 113927. ISSN 0959-8049

Ö

Ödén, J., Eriksson, K., Svensson, S. et al. (6 more authors) (2024) Technical note: Optimization functions for re‐irradiation treatment planning. Medical Physics, 51 (1). pp. 476-484. ISSN 0094-2405